Literature DB >> 22057889

hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected].

Xi Zhao1, Yonglie Chao, Pixiu Chen, Die Liu, Peng Su, Jian Sun, Xuqin Cui, Yaxiong Tang.   

Abstract

The 26S proteasome is a key component of the ubiquitin-proteasome system, a process responsible for the majority of cellular protein degradation. The function of the proteasomal ubiquitin receptor hRpn13, a component of the 26S proteasome, is not completely understood. To investigate the role of hRpn13 in the ubiquitin-proteasome system in osteoblasts, the effects of suppressing and overexpressing the hRpn13 gene on proliferation, differentiation, and function of human osteoblast-like MG63 cells were examined. After knockdown of hRpn13 by small interfering RNA, changes in osteoblast proliferation were evaluated by methyl-thiazolyl-tetrazolium assay. There was an increase in markers for osteoblast proliferation, specifically alkaline phosphatase activity, and elevated protein levels of osteocalcin, proliferating cell nuclear antigen (PCNA), and ubiquitin. Furthermore, hRpn13 knockdown also resulted in a decrease in the ratio between the gene expressions of RANKL and OPG, key players in the pathogenesis of bone diseases that influence the normal balance between bone formation and resorption. In contrast, overexpression of hRpn13 inhibited the proliferation of MG63 cells, and decreased alkaline phosphatase activity as well as protein levels of osteocalcin, PCNA, and ubiquitin while the ratio of RANKL to OPG expression increased. To confirm the function of hRpn13 in the ubiquitin-proteasome pathway, osteoblast proliferation enhancement and ubiquitin accumulation after hRpn2 knockdown was assessed. The results suggest that overexpression of hRpn13 negatively influences proliferation and osteogenic differentiation in MG63 cells. The evidence implies that hRpn13 modulates the influence of osteoblasts on osteoclasts by controlling the stability of regulatory proteins in osteoblasts. In summary, overexpression of hRpn13 promoted the activity of the ubiquitin-proteasome system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057889     DOI: 10.1007/s13105-011-0126-y

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  26 in total

Review 1.  Regulating the 26S proteasome.

Authors:  M H Glickman; V Maytal
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13.

Authors:  Muthukumar Elangovan; Choongseob Oh; Lavanya Sukumaran; Cezary Wójcik; Yung Joon Yoo
Journal:  Biochem Biophys Res Commun       Date:  2010-04-22       Impact factor: 3.575

Review 3.  [Denosumab. The first inhibitor of RANK-ligand for treatment of osteoporosis].

Authors:  Claudia Bruhn
Journal:  Med Monatsschr Pharm       Date:  2010-10

Review 4.  Ubiquitin proteasome system (UPS): what can chromatin do for you?

Authors:  Brenda C O'Connell; J Wade Harper
Journal:  Curr Opin Cell Biol       Date:  2007-02-20       Impact factor: 8.382

5.  Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.

Authors:  Yongfeng Fan; Fanxia Shen; Tim Frenzel; Wei Zhu; Jianqin Ye; Jianrong Liu; Yongmei Chen; Hua Su; William L Young; Guo-Yuan Yang
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

6.  hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.

Authors:  Xiao-Bo Qiu; Song-Ying Ouyang; Chao-Jun Li; Shiying Miao; Linfang Wang; Alfred L Goldberg
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

Review 7.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09

8.  Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation.

Authors:  Taesoo Kim; Hyun-Il Ha; Nacksung Kim; Okju Yi; Seoung Hoon Lee; Yongwon Choi
Journal:  Biochem Biophys Res Commun       Date:  2009-10-08       Impact factor: 3.575

Review 9.  Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.

Authors:  Naoyuki Takahashi; Kazuhiro Maeda; Akihiro Ishihara; Shunsuke Uehara; Yasuhiro Kobayashi
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

10.  The biological mechanisms of PCNA and BMP in TMJ adaptive remodeling.

Authors:  Zoe Potres Barnouti; Payam Owtad; Gang Shen; Peter Petocz; M Ali Darendeliler
Journal:  Angle Orthod       Date:  2011-01       Impact factor: 2.079

View more
  1 in total

1.  Characterization of Osterix protein stability and physiological role in osteoblast differentiation.

Authors:  Yanyan Peng; Kaikai Shi; Lintao Wang; Jianlei Lu; Hongwei Li; Shiyang Pan; Changyan Ma
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.